Hepatitis C virus reinfection after an intravenous drug injection
Payen, J.L.; Izopet, J.; Barange, K.; Puel, J.; Selves, J.; Pascal, J.P.
Gastroenterologie Clinique et Biologique 22(4): 469-470
1998
ISSN/ISBN: 0399-8320 PMID: 9762279 Document Number: 494191
Document emailed within 1 workday
Related Documents
Garfein, R.S.; Golub, E.T.; Greenberg, A.E.; Hagan, H.; Hanson, D.L.; Hudson, S.M.; Kapadia, F.; Latka, M.H.; Ouellet, L.J.; Purcell, D.W.; Strathdee, S.A.; Thiede, H. 2007: A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users Aids 21(14): 1923-1932Wu, N.; Li, D.; Zhu, B.; Zou, W. 2003: Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users Chinese Medical Journal 116(9): 1318-1320
Oliveira, S.A.N.; Hacker, M.A.; Oliveira, M.L.A.; Yoshida, C.F.T.; Telles, P.R.; Bastos, F.I. 2005: A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination Revista Panamericana de Salud Publica 18(4-5): 271-277
Solomon, S.S.; Celentano, D.D.; Srikrishnan, A.K.; Vasudevan, C.K.; Murugavel, K.G.; Iqbal, S.H.; Anand, S.; Kumar, M.S.; Latkin, C.; Solomon, S.; Mehta, S.H. 2010: Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India American Journal of Epidemiology 172(11): 1259-1267
Kao, J.H.; Lai, M.Y.; Chen, P.J.; Chen, D.S. 2001: Probable reinfection with hepatitis C virus in a chronic hepatitis C patient with a sustained response to combination therapy Journal of the Formosan Medical Association 100(12): 824-828
El-Ghazzawi, E.; Drew, L.; Hamdy, L.; El-Sherbini, E.; Sadek, S.e.-D.; Saleh, E. 1995: Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt Journal of the Egyptian Public Health Association 70(1-2): 127-150
Suganuma, N.; Ikeda, S.; Taketa, K.; Wang, D.H.; Yamamoto, H.; Phornphukutkul, K.; Peerakome, S.; Sitvacharanum, K.; Jittiwutikarn, J. 1998: Risk analysis of the exposure to GB virus C/hepatitis G virus among populations of intravenous drug users, commercial sex workers and male outpatients at STD clinic in Chiang Mai, Thailand: a cross-sectional case-control study Acta Medica Okayama 52(3): 161-167
Verrando, R.; Robaeys, G.; Matheï, C.; Buntinx, F. 2005: Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use Acta Gastro-Enterologica Belgica 68(1): 81-85
Othman, B.M.; Monem, F.S. 2002: Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria Saudi Medical Journal 23(4): 393-395
Jeng, L.B.; Ho, Y.C.; Lee, W.C.; Wang, C.C.; Wang, K.L.; Chen, S.C.; Chen, M.F.; Lin, D.Y.; Liaw, Y.F.; Tan, P.P. 1994: Clinical and pathologic features of hepatitis B virus reinfection after liver transplantation Transplantation Proceedings 26(4): 2263-2264
Tun, W.; Vu, L.; Adebajo, S.B.; Abiodun, L.; Sheehy, M.; Karlyn, A.; Njab, J.; Ahonsi, B.; Issa, B.K.; Idogho, O. 2013: Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria International Journal of Std and Aids 24(8): 619-625
Liang, S.H.; Lo, Y.-C.; Lin, H.-H.; Chang, S.-Y.; Chen, M.-Y.; Hsieh, S.-M.; Sheng, W.-H.; Sun, H.-Y.; Hung, C.-C.; Chang, S.-C. 2008: Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital Journal of Microbiology Immunology and Infection 41(3): 200-208
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Cavallari, A.; Vivarelli, M.; D'Errico, A.; Bellusci, R.; Scarani, P.; De Raffele, E.; Nardo, B.; Gozzetti, G. 1994: Acute necrotizing pancreatitis due to hepatitis B virus reinfection in a liver transplant recipient Transplantation Proceedings 26(6): 3649-3650
Wu, L.-M.; Xu, X.; Zheng, S.-S. 2005: Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 502-508
Devi, K.S.; Singh, N.B.; Singh, H.L.; Singh, Y.M. 2009: Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users Journal of the Indian Medical Association 107(3): 144; 146-147
Li, L.; Assanangkornchai, S.; Duo, L.; McNeil, E.; Li, J. 2014: Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012 Plos one 9(9): E106899
Will, T. 1999: Early decline in an epidemic: evolution of the prevalences of HIV, hepatitis B, hepatitis C and aminotransferases in intravenous drug abusers in Strasbourg between 1980 and 1990 Revue Medicale de la Suisse Romande 119(4): 329-334
Amitai, M.; Dickhaut, H.H.; Hasenknopf, P. 1972: Therapy of withdrawal symptoms in "fixers". (Drug abuse of adolescents by intravenous injection) Der Nervenarzt 43(3): 157-160
Heymer, B.; Schäfer, H.; Schachenmayr, W.; Spanel, R.; Bültmann, B.; Haferkamp, O.; Schmidt, W.C. 1972: Granulomatous hepatitis produced by intravenous injection of heat-killed bacteria or bacterial components into experimental animals Medecine and Chirurgie Digestives 1(5): 259-263